Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: The importance of iron availability in optimizing response
- 28 February 1994
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 96 (2) , 139-145
- https://doi.org/10.1016/0002-9343(94)90134-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patientsTransfusion, 1993
- Recombinant Human Erythropoietin in the Treatment of Anemia Associated with Human Immunodeficiency Virus (HIV) Infection and Zidovudine TherapyAnnals of Internal Medicine, 1992
- Subcutaneous use of erythropoietin in heart surgeryThe Annals of Thoracic Surgery, 1992
- Recombinant human erythropoietin for autologous blood donation: effects on perioperative red-blood-cell and serum erythropoietin productionThe Lancet, 1992
- Autologous blood transfusion with recombinant human erythropoietin in heart operationsThe Annals of Thoracic Surgery, 1991
- Recombinant human erythropoietin as adjuvant treatment for autologous blood donation.BMJ, 1990
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990
- Recombinant Human Erythropoietin for Patients with AIDS Treated with ZidovudineNew England Journal of Medicine, 1990
- Increased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin TherapyNew England Journal of Medicine, 1989
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987